The week in health tech, explained in plain English.Get the free newsletter →
October 26, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Hawaii Tops US News 2025 State Healthcare Rankings

U.S. News & World Report published its annual Best States rankings on July 28, scoring all 50 states on how well they serve residents across eight categories: healthcare, education, economy, infrastructure, opportunity, fiscal stability, crime and corrections, and natural environment. Healthcare carries significant weight at 15.51% of each state's overall score, measured through access, quality, and public health metrics.

Utah repeated as the No. 1 state overall for the fourth consecutive year, according to Becker's Hospital Review. But strong overall performance does not always track with healthcare strength, and the healthcare subcategory tells its own story about where residents get the best access and outcomes.

The rankings offer a useful benchmark for hospital leaders, payers, and policymakers weighing where care systems are working and where gaps persist. For executives and investors, state-level healthcare performance signals market conditions, coverage rates, and the kinds of infrastructure and workforce challenges that shape strategy in each region.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.